Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caridad Pontes

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Public Health|October 9, 2024
Escalating costs of innovative medicines: perspective and proposalsAntonio Vallano, Caridad Pontes
Medicina Clinica|May 28, 2013
[Missing data: warrant for search and capture]Ferran Torres, Caridad Pontes
Frontiers in Bioscience (Elite Edition)|January 2, 2013
Is the H4 receptor a new drug target for allergies and asthma?Carolina Salcedo, Caridad Pontes, Manuel Merlos
Frontiers in Pharmacology|September 18, 2023
The challenges of access to innovative medicines with limited evidence in the European UnionAntonio Vallano, Caridad Pontes, Antònia Agustí
Medicina Clinica|February 9, 2006
[Methodological recommendations of the Regulatory Agencies]Ferran Torres, Gonzalo Calvo, Caridad Pontes
BMC Health Services Research|August 15, 2021
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodiesDavid Elvira, Mercè Obach, Caridad Pontes
Inflammatory Bowel Diseases|September 6, 2014
Safety and activity of dersalazine sodium in patients with mild-to-moderate active colitis: double-blind randomized proof of concept studyCaridad Pontes, Roser Vives, Ferran Torres, et al.
Clinical Therapeutics|July 12, 2015
Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory TrialRoser Vives, Caridad Pontes, Maria Sarasa, et al.
Seminars in Liver Disease|August 29, 2017
Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?Ferran Torres, José Ríos, Joaquín Saez-Peñataro, et al.
Pharmacoeconomics|April 4, 2002
Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarctionJosep Darbà, Iñaki Izquierdo, Caridad Pontes, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Public Health|October 9, 2024
Escalating costs of innovative medicines: perspective and proposalsAntonio Vallano, Caridad Pontes
Medicina Clinica|May 28, 2013
[Missing data: warrant for search and capture]Ferran Torres, Caridad Pontes
Frontiers in Bioscience (Elite Edition)|January 2, 2013
Is the H4 receptor a new drug target for allergies and asthma?Carolina Salcedo, Caridad Pontes, Manuel Merlos
Frontiers in Pharmacology|September 18, 2023
The challenges of access to innovative medicines with limited evidence in the European UnionAntonio Vallano, Caridad Pontes, Antònia Agustí
Medicina Clinica|February 9, 2006
[Methodological recommendations of the Regulatory Agencies]Ferran Torres, Gonzalo Calvo, Caridad Pontes
BMC Health Services Research|August 15, 2021
Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodiesDavid Elvira, Mercè Obach, Caridad Pontes
Inflammatory Bowel Diseases|September 6, 2014
Safety and activity of dersalazine sodium in patients with mild-to-moderate active colitis: double-blind randomized proof of concept studyCaridad Pontes, Roser Vives, Ferran Torres, et al.
Clinical Therapeutics|July 12, 2015
Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory TrialRoser Vives, Caridad Pontes, Maria Sarasa, et al.
Seminars in Liver Disease|August 29, 2017
Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?Ferran Torres, José Ríos, Joaquín Saez-Peñataro, et al.
Pharmacoeconomics|April 4, 2002
Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarctionJosep Darbà, Iñaki Izquierdo, Caridad Pontes, et al.
Pageof 9